Abstract
Development of Antibiotic Resistance in bacteria has become a major public health concern. Bacteria from Clinical and Non Clinical settings have become resistant to several antibiotics. Self-medication, Excessive use of antibiotics and Incomplete antibiotic treatment is the Primary cause of resistance to antibiotics. Studies have shown that the Prophylactic use of “non priority” antimicrobials in Animal husbandry has lead to transmission of resistant bacteria Via Food chain and Environment affecting the human health.
Development of Intrinsic antibiotic resistance to bacteria is mediated by various mechanisms like Minimization of Intracellular concentration of antibiotic due to poor penetration into bacterium or Antibiotic Efflux, Modification of antibiotic target by gene mutation and Inactivation of antibiotic by hydrolysis. Bacteria can also acquire resistance to antibiotics via mutation in Chromosomal genes and by horizontal transfer.
It is estimated that 700,000 deaths occur annually due to AMR Worldwide affecting every country. Keeping in view of this current status of AMR, there is need for the development of Genetically engineered phages to deliver antimicrobial agents to bacteria; Synthesis of Metal Nanoparticles which affect the bacterial cell and their metabolic pathways; Production of Antimicrobial Peptides as they are Host Defense Effector molecules in the living organism and Synthesis of New antibiotics and use of Prebiotics and Quroum sensing Inhibitors as an Alternative Approach to Combat Antibiotic resistance or to treat Pathogenic bacterial Infection. Preventive measures have been under taken at National level and International level.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahamad RS, Fakhimi A, Hamid RS et al (2007) Synthesis and effect of silver nano particles on the anti bacterial activity of different antibiotics against S. aureus and E. coli. Nanomed Nanotechnol Biol Med 3:168–171. https://doi.org/10.1016/j.nano.2007.02.001
Arthur M, Reynolds PE, Depardien F et al (1996) Mechanisms of glycopeptides resistance in enterococci. J Infect Dis 32:11–16
Bartlett JG, Gilbert DN, Spellberg B (2013) Sevenways to preserve the miracle of antibiotics. Clin Infect Dis 56(10):1445–1450
Caroline W, Kasman LM, David AS, Phillip AW, Dolan JW, Schmidt MG, Norris JS (2003) Antimicrob Agents Chemother 47(4):1301–1307. https://doi.org/10.1128/AAC.47.4.1301-1307.2003
Dabrowska K, Switala-jelenk, Opolski A et al (2005) Bacteriophage penetration in vertebrates. J Appl Microbiol 98:7–13. https://doi.org/10.1073/pnas.0914030107
Dewey JS, Savva CG, White RL, Vitha S, Holzenburg A, Young R (2010) Micron scale holes terminate the phage infection cycle. Proc Natl Acad Sci USA 107:2219–2223. https://doi.org/10.1073/obas.091430107
Doyle MP (2006) Antimicrobial resistance: implications for the food system. Compr Rev Food Sci Food Saf 5:71–137
Flamm RK, Rhomberg PR, Simpson KM et al (2015) In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms. Antimicrob Agents Chemother 59(3):1751–1754
Holcik M, Iyer VN (1997) Conditionally Lethal genes associated with bacterial plasmids. Microbiology 143:3403–3416
Hwang IY, Koh E, Wong A et al (2017) Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeurginosa gut infection in animal models. Nat Commun 8:15028
Janiszewska J, Urbanczyk LZ (2007) Amphillic dendrimeric peptides as model non sequential Pharmacophores with Antimicrobial properties. J Mol Microbiol Biotechnol 13:220–225
Katayama Y, Ito T, Hiramatsu K (2000) A new class of genetic element, Staphylococcus casette chromosome mec, enccodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 44(6):1549–1555. https://doi.10.1128/aac44.6.1549-1555.2000
Kumaraswamy KK, Toleman MA, Walsh TR et al (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan and the U.K. a molecular, biological and epidemiological study. Lancet Infect Dis 10(9):597–602
Kim L, Mc Gee L, Tom Czyk S, Beall B (2016) Biological and epidemiological features of antibiotic-resistance streptococcus pneumonia in pre-and post conjugate vaccine era. Clin Microbiol Rev 29(3):525–552
Linton AH (1997) Antibiotic resistance: the present situation reviewed. Vet Rec 100:354–360
MacFadden DR, McGough SF, Fisman D et al (2018) Antibiotic resistance increases with local temperature. Nat Clim Chang 8(6):510–514. https://doi.org/10.1038/541558-018-0161-6
Maffoli SI, Yuzhang DD et al (2017) Antibacterial nucleoside Analog inhibitor of bacterial polymerase. Cell 169(7):1240. http://dx.doi.org/10.1016/j.cell.2017.05.042
Merril CR, Scholl D, Adhya S (2006) Phage therapy. In: Calender R (ed) The bacteriophages. Oxford University Press, New York, pp 725–741
Michael CA, Gillings MR, Holmes AJ et al (2004) Mobile gene casettes:a fundamental resource for bacterial evolution. Am Nat 164:1–12
Millette M, Cornut G, Dupont C et al (2008) Capacity of Human nisin- and pediocin producing lactic acid bacteria to reduce intestinal Colonization by Vancomycin-resistant enterococci. Appl Environ Microbiol 74:1997–2003
Minandri F, Bonchi C, Frangipani E et al (2014) Promises and failures of gallium as an antibacterial agent. Future Microbiol 9(3):379–397
Norris JS, West water C, Schofield D (2000) Prokaroytic Gene therapy to combat Multi drug resistant bacterial infection. Gene Ther 7:723–725
Pourmand A, Mazer-Amirshahi M, Jasani G, May L (2017) Emerging trends in antibiotic resistance: implications for emergency medicine. Am J Emerg Med 35(8):1172–1176. https://doi.org/10.1016/j.ajem2017.03.010.Epub
Qiu XQ, Wang H, Lu XF et al (2003) An Engineered multidomain bactericidal peptide as a Model for targetted antibiotics against specific bacteria. Nat Biotechnol 21:1480–1485
Quintilani R, Evers S, Courvalin P (1993) The vanβ gene confers various levels of self-transferable resistance to vancomycin in enterococci. J Infect Dis 167:1220–1223
Rebekah M, Dedrick CA, Gurerrero B et al (2019) Engineered bacteriophages for treatment of a patient with disseminated drug resistant Mycobacterium abscessus. Nat Med 25(5):730. https://doi.org/10.1038/S41591-019-0437-Z
Reviews on Antimicrobial Resistance. Tackling drug-resistant infections globally: final report and recommendations. 2016. Available from: https://amr-review.org/home.html
Reardon S (2017) Modified viruses deliver death to antibiotic resistant bacteria. Nature 546:586–587. https://doi.org/10.1038/nature2017.22173
Sarker SA, McCallin S, Barnetto C et al (2012) Oral T-4 like phage CockTail application to healthy adult volunteers from Bangladesh. Virol 434:222–232. https://doi.org/10.1016/j.virol.2012.09.002
Shi Y, YanY JW, Du B, Meng Y, Wang H, Sun J (2012) Characterization and determination of holing protein of streptococcus suis bacteriophage SMP in heterologous host. Virol J 9:70. https://doi.org/10.1186/1743-4229-70
Simon P, David VV, Roger E, et al (2018) Cefiderocol versus imipenem-cliastatin for the treatment of complicated urinary tract infections caused by Gram negative uropathogens; a phase2 randomised, doubleblind, noninferiority trial. Lancet Infect Dis. https://doi.org/10.1016/s1473-3099(18)30554-1
Singla S, Harjari K, Razak WS, Katare OP, Chhibber S (2016) Phospholipid vegides encapsulated bacteriophage: a novel approach to enhance phage biodistribution. J Virol Method 236:68–76. https://doi.org/10.1186/1743-422x-9-70
Smith HW, Huggins MB (1983) Effectiveness of Phages in treating experimental E. coli diarrhoea in calves, piglets and lambs. J Gen Microbiol 129(8):2659–2675
Smith HW, Huggins MB, Shaw KM (1987) The control of Experimental E. coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol 133(5):1111–1126
Thirabunyanon M, Thongwittaya N (2012) Protection activity of a novel probiotic strain of Bacillus subtilis against Salmonella Enteritidis infection. Res Vet Sci 93:74–81. https://doi.org/10.1016/j.rvsc.2011.08.008
Viswanathan VK (2014) Off label abuse of antibiotics by bacteria. Gut Microbes 5(1):3–4. https://doi.org/10.4161/gmic.2807
Weber Dabrowska B, Zimecki M, Mulczyk M et al (2002) Effect of phage therapy on the turnover and function of Pheripheral neutrophils. FEMS Immunol Med Microbiol 34:135–138. https://doi.org/10.1111/j.1574-695X.2002.tb00614.x
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Premlatha, M. (2019). Microbial Resistance to Antibiotics. In: Mandal, S., Paul, D. (eds) Bacterial Adaptation to Co-resistance. Springer, Singapore. https://doi.org/10.1007/978-981-13-8503-2_4
Download citation
DOI: https://doi.org/10.1007/978-981-13-8503-2_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8502-5
Online ISBN: 978-981-13-8503-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)